Results 21 to 30 of about 5,646,776 (202)

Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial

open access: yesJournal of Clinical and Translational Science, 2023
Tesamorelin, a synthetic growth hormone-releasing hormone, is indicated for the reduction of visceral adipose tissue (VAT) in people with HIV. Here, we performed a post hoc analysis of participants receiving tesamorelin for 26 weeks in a phase III ...
Farah Rahman   +6 more
doaj   +1 more source

The role of Gai in the Gonadotropin-releasing hormone (GnRH) receptor inhibition of cell proliferation [PDF]

open access: yes, 2011
Includes abstract.Includes bibliographical references (leaves 72-78).The activation of Gonadotropin-releasing hormone receptor (GnRHR) by the GnRH ligand has been shown to mediate antiproliferative effects in extra-pituitary cells and in reproductive ...
Phillips, Pumza Samantha
core   +1 more source

Investigating crosstalk in lipid rafts between the glucocorticoid receptor and gonadotropin-releasing hormone receptor signaling pathways in a gonadotrope cell line [PDF]

open access: yes, 2010
Includes abstract.Includes bibliographical references (leaves 121-158).A recent study from the Hapgood laboratory demonstrated the presence of a novel crosstalk mechanism between the glucocorticoid receptor (GR) and gonadotropin-releasing hormone ...
Wehmeyer, Lance
core   +1 more source

Growth hormone-releasing hormone, growth hormone, and neuroendocrine tumors

open access: yesJournal of Clinical & Translational Endocrinology
Neuroendocrine tumors (NETs) are known to produce growth hormone (GH) and growth hormone-releasing hormone (GHRH) leading to acromegaly. Ectopic production of these hormones can lead to ectopic acromegaly which is very rare.
Maham Shahid, Christian A. Koch
doaj   +1 more source

Afferent Neuronal Control of Type-I Gonadotropin Releasing Hormone Neurons in the Human. [PDF]

open access: yes, 2013
Understanding the regulation of the human menstrual cycle represents an important ultimate challenge of reproductive neuroendocrine research. However, direct translation of information from laboratory animal experiments to the human is often complicated ...
Zsolt Liposits   +3 more
core   +1 more source

Ghrelin

open access: yesEndocrinology Research and Practice, 2022
Growth hormone secretagogues are synthetic peptidyl and non- peptidyl molecules that possess growth hormone releasing activity. Ghrelin is an endogenous natural ligand for the growth hormone secretagogue receptor that has recently been isolated from the ...
Serdar Güler   +2 more
doaj   +2 more sources

Peripheral Injection of Chicken Growth Hormone-Releasing Hormone Inhibits Feeding Behavior in Chicks

open access: yesThe Journal of Poultry Science, 2016
Growth hormone-releasing hormone (GHRH), a stimulator of growth hormone (GH) secretion, is known to have several physiological roles such as the regulation of feeding behavior in mammals. Recently, we have reported that central injection of chicken GHRH
Tetsuya Tachibana   +5 more
doaj   +1 more source

A study of association between genetic markers in candidate genes and reproductive traits in one generation of a commercial broiler breeder hen population [PDF]

open access: yes, 2004
Markers of alleles for three physiological candidate genes for reproductive traits, growth hormone (GHR), gonadotropin-releasing hormone receptor (GNRHR) and neuropeptide Y (NPY) were assessed for the association with the total egg production, number of ...
I C Dunn   +11 more
core   +1 more source

The Decreased Growth Hormone Response to Growth Hormone Releasing Hormone in Obesity Is Associated to Cardiometabolic Risk Factors

open access: yesMediators of Inflammation, 2010
The aim of the present study was to evaluate the relationship between GHRH-induced GH secretion in obese premenopausal women and cardiovascular risk markers or insulin resistance. Premenopausal obese women, aged 35–52 years, were studied.
Fernando Cordido   +4 more
doaj   +1 more source

Growth hormone-releasing hormone agonist attenuates vascular calcification in diabetic db/db mice

open access: yesFrontiers in Cardiovascular Medicine, 2023
IntroductionVascular calcification (VC) is an independent risk factor for cardiovascular diseases. VC increases mortality of all-causes. VC is one of most common cardiovascular complications in type II diabetes.
Hao-Lin Ren   +18 more
doaj   +1 more source

Home - About - Disclaimer - Privacy